Connect with us
The pharmaceutical industry sees a surge in R&D investment, reaching $145.5 billion last year, 4.5% higher than drug launch budgets in 2022. Deloitte's report on pharmaceutical...
Beyond the 27 EU countries, the pharmaceutical industry maintains its relevance in Switzerland and ranks as the country's second most exported non-agricultural product, followed by blood...
One of the measures being implemented by the pharmaceutical industry through Sigre, is the system for the management of waste medicines and their packaging of domestic...
In 2022, 86% of Spanish companies in the sector have launched new initiatives throughout the year aimed at greater digitization, after nine out of ten operators...
The Iqvia report also focuses on the place of origin of the research. This confirms the decline that is being experienced in Europe in the field...
Within the pharmaceutical investment in research and development it is necessary to distinguish between different parts of the process. Almost $78 million (€66 million) were allocated...
Managed and owned by Bernard Tannoury, the Benta Pharma group has achieved sales of $77.5 million in 2019 and distributes its products in more than 40...
All the listed pharmaceutical companies have taken a step back on the stock exchange, with the exception of Pharma Mar and Reig Jofre. Pharma Mar has...
The Spanish pharmaceutical sector does not slow down because of the COVID-19: investment increased by 4.2% in the first quarter. Grifols, Almirall, Rovi, Pharma Mar and...
Grifols, Almirall, Reig Jofre, Rovi, Pharma Mar, and Faes Farma increased their joint debt to financial institutions to $8.8 million (€7.76 million) in 2019. The company...